| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |